TransThera Sciences (Nanjing), Inc. (HKG:2617)
87.55
+17.00 (24.10%)
Sep 10, 2025, 1:45 PM HKT
HKG:2617 Statistics
Total Valuation
HKG:2617 has a market cap or net worth of HKD 28.00 billion. The enterprise value is 27.31 billion.
Market Cap | 28.00B |
Enterprise Value | 27.31B |
Important Dates
The last earnings date was Monday, August 25, 2025.
Earnings Date | Aug 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HKG:2617 has 396.90 million shares outstanding. The number of shares has increased by 0.08% in one year.
Current Share Class | 301.67M |
Shares Outstanding | 396.90M |
Shares Change (YoY) | +0.08% |
Shares Change (QoQ) | +0.16% |
Owned by Insiders (%) | 12.06% |
Owned by Institutions (%) | 28.81% |
Float | 118.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 43.89 |
P/TBV Ratio | 43.93 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -62.89 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.89, with a Debt / Equity ratio of 0.01.
Current Ratio | 5.89 |
Quick Ratio | 5.79 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1,490.65 |
Financial Efficiency
Return on equity (ROE) is -65.31% and return on invested capital (ROIC) is -42.58%.
Return on Equity (ROE) | -65.31% |
Return on Assets (ROA) | -35.56% |
Return on Invested Capital (ROIC) | -42.58% |
Return on Capital Employed (ROCE) | -71.46% |
Revenue Per Employee | n/a |
Profits Per Employee | -3.59M |
Employee Count | 121 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 45.23 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 79.02 |
Average Volume (20 Days) | 332,455 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -456.24M |
Pretax Income | -434.19M |
Net Income | -434.19M |
EBITDA | -453.16M |
EBIT | -456.24M |
Earnings Per Share (EPS) | -1.14 |
Balance Sheet
The company has 698.55 million in cash and 3.35 million in debt, giving a net cash position of 695.20 million or 1.75 per share.
Cash & Cash Equivalents | 698.55M |
Total Debt | 3.35M |
Net Cash | 695.20M |
Net Cash Per Share | 1.75 |
Equity (Book Value) | 637.96M |
Book Value Per Share | 1.67 |
Working Capital | 590.45M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
HKG:2617 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.08% |
Shareholder Yield | n/a |
Earnings Yield | -1.55% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |